🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

ValueAct Capital (Mason Morfit)’s RYAN Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+3.68 M Shares
Current Position
3.68 M Shares
$136.24 M Value

ValueAct Capital (Mason Morfit)'s RYAN Position Overview

ValueAct Capital (Mason Morfit) (via Valueact Holdings, L.P.) currently holds 3.68 M shares of Ryan Specialty Holdings, Inc. (RYAN) worth $136.24 M, representing 2.21% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, ValueAct Capital (Mason Morfit) has initiated a new position in RYAN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

ValueAct Capital (Mason Morfit)'s Ryan Specialty Holdings (RYAN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Ryan Specialty Holdings (RYAN) Trades by ValueAct Capital (Mason Morfit)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +3.68 M New Buy 3.68 M $37.00

ValueAct Capital (Mason Morfit)'s Ryan Specialty Holdings Investment FAQs

ValueAct Capital (Mason Morfit) first purchased Ryan Specialty Holdings, Inc. (RYAN) in Q3 2026, acquiring 3,682,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

ValueAct Capital (Mason Morfit) has held Ryan Specialty Holdings, Inc. (RYAN) for 1 quarters since Q3 2026.

ValueAct Capital (Mason Morfit)'s largest addition to Ryan Specialty Holdings, Inc. (RYAN) was in Q3 2026, adding 3,682,200 shares worth $136.24 M.

According to the latest 13F filing for Q3 2026, ValueAct Capital (Mason Morfit)'s firm, Valueact Holdings, L.P., owns 3,682,200 shares of Ryan Specialty Holdings, Inc. (RYAN), valued at approximately $136.24 M.

As of the Q3 2026 filing, Ryan Specialty Holdings, Inc. (RYAN) represents approximately 2.21% of ValueAct Capital (Mason Morfit)'s publicly disclosed stock portfolio, making it one of their key holdings.

ValueAct Capital (Mason Morfit)'s peak holding in Ryan Specialty Holdings, Inc. (RYAN) was 3,682,200 shares, as reported at the end of Q3 2026.